Indivior PLC(INDV) - 2025 Q1 - Quarterly Results

Exhibit 99.1 The "Company" refers to Indivior PLC and its consolidated subsidiaries. "Our first quarter results were in line with our planning assumptions and consistent with our FY 2025 outlook," said Mark Crossley, Chief Executive Officer. "Net revenue performance was primarily impacted by intensified generic competition for SUBOXONE Film in the U.S. and the discontinuation of PERSERIS in the prior year. SUBLOCADE continued to grow solidly year-over-year in organized health systems (OHS), but as expected, ...